Axogen

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Axogen and other ETFs, options, and stocks.

About AXGN

Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. It also provides products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. 

CEO
Michael D. Dale
CEOMichael D. Dale
Employees
622
Employees622
Headquarters
Alachua, Florida
HeadquartersAlachua, Florida
Founded
1977
Founded1977
Employees
622
Employees622

AXGN Key Statistics

Market cap
1.60B
Market cap1.60B
Price-Earnings ratio
-90.88
Price-Earnings ratio-90.88
Dividend yield
Dividend yield
Average volume
1.04M
Average volume1.04M
High today
$31.00
High today$31.00
Low today
$30.61
Low today$30.61
Open price
$31.38
Open price$31.38
Volume
7.14K
Volume7.14K
52 Week high
$36.00
52 Week high$36.00
52 Week low
$9.22
52 Week low$9.22

Stock Snapshot

Axogen(AXGN) stock is priced at $31.00, giving the company a market capitalization of 1.6B. It carries a P/E multiple of -90.88.

On 2026-03-23, Axogen(AXGN) stock moved within a range of $30.61 to $31.00. With shares now at $31.00, the stock is trading +1.3% above its intraday low and 0.0% below the session's peak.

Trading activity shows a volume of 7.14K, compared to an average daily volume of 1.04M.

The stock's 52-week range extends from a low of $9.22 to a high of $36.00.

The stock's 52-week range extends from a low of $9.22 to a high of $36.00.

AXGN News

Nasdaq 1d
This $6.5 Million Healthcare Trim Comes Amid a 71% Stock Surge and 20% Revenue Growth

Key Points DAFNA Capital Management sold 265,456 AXGN shares in the fourth quarter, with an estimated transaction value of $6.53 million based on quarterly ave...

This $6.5 Million Healthcare Trim Comes Amid a 71% Stock Surge and 20% Revenue Growth
Simply Wall St 4d
Is It Too Late To Consider Axogen After Its Strong Three Year Run

If you are wondering whether Axogen at around US$30.94 is still good value after a strong run, or if you are arriving late to the story, this breakdown will hel...

Is It Too Late To Consider Axogen After Its Strong Three Year Run

Analyst ratings

91%

of 11 ratings
Buy
90.9%
Hold
9.1%
Sell
0%

People also own

Based on the portfolios of people who own AXGN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.